A carregar...

Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma

Hormonal therapies such as progestins have only modest activity in the treatment of advanced endometrial cancer. Mechanisms of resistance to progestin therapy are not well understood. However, activation of the PI3K/AKT/mTOR pathway has been associated with resistance to hormonal therapy and alterat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Hematol Rev
Main Authors: Stringer, Erica M, Fleming, Gini F
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4243922/
https://ncbi.nlm.nih.gov/pubmed/25431800
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!